are now
Press Release
Nexelis and JOINN Laboratories sign Letter of Intent entering partnership to support international sponsors in China in the bioanalytical field
March 30, 2021 | Press Release
Laval, Canada and Beijing, China, March 30, 2021 – Nexelis and JOINN Laboratories announced today that the two companies have […]
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK
20 Jan 2021 | Press Release
Laval, Quebec, and Marburg, Germany, January 20, 2021. Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider […]
CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
02 Oct 2020 | Press Release
Five laboratories initially selected to work together as part of centralised network to reliably assess and compare immunological responses generated […]
Nexelis Acquires Integrated Bioanalytical CRO AIT Bioscience
July 22, 2020 | Press Release
Laval, Quebec, and Indianapolis, IN, July 22, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners and a leading […]